Effect of molecular chaperones on aberrant protein oligomers in vitro: super- versus sub-stoichiometric chaperone concentrations by Cappelli, S et al.
Biol. Chem. 2016; aop
aPresent address: Department of Molecular Medicine, University of 
Pavia, Pavia, Italy and Department of Physics, University of Genoa, 
Genoa, Italy.
*Corresponding author: Fabrizio Chiti, Department of Biomedical 
Experimental and Clinical Sciences, Section of Biochemistry, 
University of Florence, Viale Morgagni 50, I-50134, Florence, Italy, 
e-mail: fabrizio.chiti@unifi.it
Sara Cappelli, Roberta Cascella and Cristina Cecchi: Department 
of Biomedical Experimental and Clinical Sciences, Section of 
Biochemistry, University of Florence, Viale Morgagni 50, I-50134, 
Florence, Italy
Amanda Penco and Annalisa Relini: Department of Physics, 
University of Genoa, Via Dodecaneso 33, I-16136, Genoa, Italy
Benedetta Mannini: Department of Biomedical Experimental and 
Clinical Sciences, Section of Biochemistry, University of Florence, 
Viale Morgagni 50, I-50134, Florence, Italy; and Department of 
Chemistry, University of Cambridge, Lensfiled Road, CB2 1EW 
Cambridge, UK
Mark R. Wilson and Heath Ecroyd: Illawarra Health and Medical 
Research Institute and School of Biological Sciences, University of 
Wollongong, Northfields Avenue, Wollongong 2522, NSW, Australia
Xinyi Li and Joel N. Buxbaum: Department of Molecular and 
Experimental Medicine, The Scripps Research Institute, 
10550 North Torrey Pines Road, La Jolla, CA 92037, USA
Christopher M. Dobson: Department of Chemistry, University of 
Cambridge, Lensfiled Road, CB2 1EW Cambridge, UK
Sara Cappelli, Amanda Pencoa, Benedetta Mannini, Roberta Cascella, Mark R. Wilson, 
Heath Ecroyd, Xinyi Li, Joel N. Buxbaum, Christopher M. Dobson, Cristina Cecchi, 
Annalisa Relini and Fabrizio Chiti*
Effect of molecular chaperones on aberrant 
protein oligomers in vitro: super-versus  
sub-stoichiometric chaperone concentrations
DOI 10.1515/hsz-2015-0250
Received September 10, 2015; accepted January 11, 2016
Abstract: Living systems protect themselves from aberrant 
proteins by a network of chaperones. We have tested in vitro 
the effects of different concentrations, ranging from 0 to 
16 μm, of two molecular chaperones, namely αB-crystallin 
and clusterin, and an engineered monomeric variant of 
transthyretin (M-TTR), on the morphology and cytotoxic-
ity of preformed toxic oligomers of HypF-N, which repre-
sent a useful model of misfolded protein aggregates. Using 
atomic force microscopy imaging and static light scatter-
ing analysis, all were found to bind HypF-N oligomers and 
increase the size of the aggregates, to an extent that cor-
relates with chaperone concentration. SDS-PAGE profiles 
have shown that the large aggregates were predominantly 
composed of the HypF-N protein. ANS fluorescence meas-
urements show that the chaperone-induced clustering 
of HypF-N oligomers does not change the overall solvent 
exposure of hydrophobic residues on the surface of the 
oligomers. αB-crystallin, clusterin and M-TTR can dimin-
ish the cytotoxic effects of the HypF-N oligomers at all 
chaperone concentration, as demonstrated by MTT reduc-
tion and Ca2+ influx measurements. The observation that 
the protective effect is primarily at all concentrations of 
chaperones, both when the increase in HypF-N aggregate 
size is minimal and large, emphasizes the efficiency and 
versatility of these protein molecules.
Keywords: molecular chaperones; protein aggregates; 
protein homeostasis; protein misfolding.
Introduction
A large number of pathological conditions arise from the 
failure of polypeptide chains to adopt or to remain in their 
native conformational states (Chiti and Dobson, 2006). 
These conditions are generally described as protein mis-
folding, or protein conformational diseases and may result 
in loss of function or a gain of toxic function. Most of these 
diseases are associated with the conversion of specific pro-
teins from their soluble states into aggregated species that 
thus become deposited within organs and tissues, either 
as intracellular inclusions or their deposition as extracel-
lular deposits (Chiti and Dobson, 2006; Rambaran and 
Serpell, 2008). Molecules with chaperone activity are key 
components of the quality control processes used by living 
systems to maintain protein homeostasis in the highly 
crowded cellular environment. The majority of chaperones 
are located within cells (Bukau et  al., 2006; Hartl et  al., 
2011), but the presence of protective guardians in the extra-
cellular environment collectively referred to as extracellu-
lar chaperones is now widely acknowledged (Wyatt et al., 
2012, 2013). Typically, chaperones prevent the aggregation 
of unfolded polypeptide chains (‘holdase’ activity) and/
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or promote their de novo protein folding or refolding, i.e. 
‘foldase’ activity (Hartl et al., 2011; Kim et al., 2013). Some 
molecular chaperones can also disaggregate protein aggre-
gates (Weibezahn et al., 2005; Hodson et al., 2012; Winkler 
et al., 2012) or cooperate with proteases to facilitate protein 
degradation (Pickart and Cohen, 2004; Alexopoulos et al., 
2012; Li and Lucius, 2013).
In addition to these functions, chaperones have 
recently been found to suppress in vitro the toxic effects 
of protein aggregates after the aggregates have formed 
(Ojha et al., 2011; Mannini et al., 2012; Binger et al., 2013; 
 Cascella et  al., 2013a,b). In particular, it has been found 
for a range of systems that misfolded protein oligomers, 
incubated with sub-stoichiometric concentrations of chap-
erones in vitro, can be converted into large aggregates with 
substantially reduced toxicity, in the absence of any sig-
nificant structural reorganization of the individual mol-
ecules within the aggregates (Mannini et al., 2012). It was 
also found that fibrils formed by apolipoprotein C-II were 
converted into large fibrillar tangles in the presence of a 
small heat shock protein (Binger et al., 2013). In a recent 
report it was found that long-lived daf-2 mutant Caeno-
rhabditis elegans strains were characterized by the accu-
mulation of large chaperone-containing aggregates during 
aging, relative to age-matched wild-type controls that had 
a normal lifespan (Walther et  al., 2015). This chaperone-
driven aggregation process was suggested to neutralize 
potentially harmful, soluble, oligomeric proteins into 
innocuous large aggregates. It was found to maintain the 
proteome in the mutant nematodes, therefore represent-
ing an important part of their protein homeostasis system 
and ability to extend their lifespan (Walther et al., 2015). 
Hence, it appears that the ability of chaperones to neutral-
ize preformed toxic aggregates is an important feature of 
the behavior of these molecules, and in the present paper 
we describe further studies of this phenomenon over a 
wide range of concentrations both above and below stoi-
chiometric ratios of chaperones to oligomers.
We have tested the effects of different concentrations 
of two recognized molecular chaperones, namely αB-
crystallin (αBc), as an example of an intracellular chaper-
one, and clusterin (Clu), as an example of an extracellular 
chaperone, on the toxicity of oligomers formed from the 
N-terminal domain of HypF protein from Escherichia 
coli (HypF-N). We have also tested on the same aberrant 
protein oligomers the effect of various concentrations of 
an engineered monomeric variant of transthyretin (M-TTR) 
containing two mutations (Phe87Met and Leu110Met) that 
prevent it from forming normal tetramers (Jiang et  al., 
2001). Although M-TTR and tetrameric TTR are not gener-
ally classified as chaperones, they have been found to act 
in a chaperone-like manner on a subset of amyloidogenic 
client proteins: they effectively inhibit the aggregation of 
the amyloid β peptide (Aβ) associated with Alzheimer’s 
disease and suppress the toxicity of these aggregates and 
other oligomeric proteins (Li et  al., 2011; Cascella et  al., 
2013a; Li et  al., 2013; Buxbaum et  al., unpublished). 
Further, in neurons (but not in liver) TTR has been shown 
to be regulated by the stress responsive heat shock factor 
1 (HSF-1) in parallel with the classical heat shock proteins 
Hsp40, Hsp70 and Hsp90 (Wang et al., 2014).
We decided to assess the effect of these three proteins 
on HypF-N oligomers because HypF-N is an amyloidogenic 
protein and a good model system for a number of reasons. 
First, it forms fibrils that are morphologically, tinctori-
ally and structurally similar to those found in amyloid 
deposition diseases (Chiti et al., 2001; Relini et al., 2004). 
Second, HypF-N forms pre-fibrillar oligomers that are 
toxic to cells in culture and in animal models (Bucciantini 
et al., 2002, 2004; Cecchi et al., 2005; Baglioni et al., 2006; 
Pellistri et  al., 2008). Furthermore, HypF-N pre-fibrillar 
oligomers have similar pathogenic effects as Aβ oligomers 
on cells at the biochemical, molecular, electrophysiologi-
cal and animal level (Bucciantini et al., 2004; Tatini et al., 
2013). Moreover, under two different solution conditions 
(conditions A and B, respectively), HypF-N very reproduc-
ibly forms two well-characterized types of oligomers with 
similar morphology but different toxicities (Campioni 
et al., 2010; Zampagni et al., 2011; Evangelisti et al., 2012; 
Tatini et al., 2013; Mannini et al., 2014).
In this study we have found that αBc, Clu and M-TTR 
can promote clustering of the HypF-N type A oligomers 
into larger species, with sizes that in each case increase 
linearly with chaperone concentration. We have also 
observed that concentrations of each of the three chaper-
ones below as well as above stoichiometric ratios relative 
to HypF-N are sufficient to suppress the toxicity of HypF-N 
oligomers. Indeed, inhibition of HypF-N oligomer toxic-
ity is also achieved even under conditions when there 
is minimal increase in oligomer size, demonstrating the 
efficacy of these species to suppress oligomer toxicity by a 
variety of mechanisms.
Results
HypF-N oligomers are insoluble over a wide 
range of protein concentration
The formation of HypF-N oligomers was verified by 
sodium dodecylsulfate polyacrylamide gel electrophoresis 
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(SDS-PAGE) samples containing oligomeric and native 
HypF-N at 4 μm concentration (equivalent monomer con-
centration) were centrifuged in order to separate pellet (P) 
and supernatant (SN) fractions and these were loaded onto 
a gel. In the sample containing native HypF-N, the HypF-N 
band (MW ~10.5 kDa) was observed only in the SN fraction, 
whereas in the sample containing HypF-N oligomers the 
HypF-N band was found only in the P fraction (Figure 1A). 
The larger intensity of the latter band arises from the higher 
amount of protein loaded onto the electrophoretic gel.
In our prior studies of HypF-N oligomers and chap-
erones, we used preformed HypF-N oligomers at an 
equivalent monomer concentration of 12 μm (Mannini 
et al., 2012; Cascella et al., 2013a), a concentration that is 
too high for the purpose of studying the effect of a wide 
range of chaperone concentrations, ranging from sub- to 
super-stoichiometric, on the morphology and cytotoxicity 
Figure 1: Preliminary analysis of HypF-N oligomers.
(A) SDS-PAGE analysis of the pellet (P) and supernatant (SN) frac-
tions obtained from samples containing native HypF-N or HypF-N oli-
gomers through centrifugation. (B) Static light scattering intensity 
expressed as kilocounts per second (kcps) of HypF-N oligomers at 
different concentrations. The data can be fit with a straight line, 
described by the equation in the figure.
of HypF-N oligomers. In particular, super-stoichiometric 
concentrations (i.e.  >  > 12 μm) are too high, due to the dif-
ficulties associated with the poor solubility of some chap-
erones at these concentrations (see below). To choose the 
range of concentration of HypF-N oligomers optimal for 
the current investigation, the oligomers were diluted into 
20 mm potassium phosphate, pH 7.0, to final concentra-
tions ranging from 0 to 14 μm (monomer concentration) 
and analyzed using static light scattering (SLS). A linear 
relationship was found between the concentration of 
HypF-N oligomers and the intensity of scattered light, sug-
gesting that lower protein concentrations do not induce 
dissociation of the oligomers and the light scattering 
intensity is linearly proportional to the concentration of 
aggregated particles in suspension (Figure 1B). A concen-
tration of 4 μm was therefore chosen as a good compro-
mise to evaluate the effect of both sub-stoichiometric and 
super-stoichiometric chaperone concentrations on the 
size and toxicity of HypF-N oligomers.
The size of HypF-N oligomers increases with 
αBc, Clu and M-TTR concentration
To investigate the effects of different concentrations of 
αBc, Clu and M-TTR on HypF-N aggregate size, we incu-
bated the oligomers (at a concentration equivalent to 4 μm 
monomer) in the presence of increasing concentrations of 
each chaperone (0–16 μm) and measured the intensity of 
scattered light (Figure 2A–C). Relative to the sample con-
taining oligomers alone, the intensity of scattered light 
was found to increase with the concentration of each 
chaperone. The increase in light scattering intensity was 
less marked at low concentrations of each chaperone, but 
became highly significant at high concentrations.
The soluble chaperones provide a small but sig-
nificant contribution to light scattering. To exclude the 
possibility that the observed increase in light scattering 
intensity coinciding with increases in chaperone concen-
tration solely arose from the chaperones themselves, we 
performed control experiments using 16 μm αBc, Clu or 
M-TTR alone, which corresponds to the highest chaperone 
concentration used in all our experiments. The low values 
of light scattering intensity observed with 16 μm αBc, Clu 
and M-TTR alone suggest that the soluble chaperones 
cannot account for the increase in light scattering inten-
sity observed in the samples containing both oligomers 
and chaperones (Figure 2).
We also used AFM imaging to determine the 
morpho logy and size of HypF-N oligomers in the pres-
ence of increasing concentrations of αBc, Clu or M-TTR 
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Figure 2: Static light scattering intensity measurements (kcps) of HypF-N oligomers (4 μm monomer concentration) incubated with the indi-
cated concentrations of αBc (A), Clu (B) and M-TTR (C). Samples containing 16 μm αBc, Clu or M-TTR are also reported. Error bars correspond 
to standard errors (SEM) of the means of 4 measurements. The single, double and triple asterisks indicate a significant difference (p  ≤  0.05, 
p  ≤  0.01, p  ≤  0.001, respectively) relative to the sample containing the oligomers alone.
(Figure 3 A–C). In the absence of chaperones the oligom-
ers appear as small spheroids with a height of 2.8±0.2 nm 
(n = 101). This value results from the cross sectional 
measurements corrected by a shrinking factor of 1.7 and 
is consistent with that previously reported for HypF-N 
oligomers (Campioni et  al., 2010). In the presence of 
αBc, Clu and M-TTR at low concentration, we observed 
aggregates with similar or only slightly higher size. In 
the presence of the same three proteins at higher con-
centration, we observed discrete larger aggregates. The 
largest aggregates were found in samples containing the 
highest concentration of the chaperones. A quantitative 
analysis of the sizes of various HypF-N aggregates in the 
presence of each  chaperone showed that both height and 
width values increase with αBc, Clu and M-TTR concen-
tration (Figure 3D). We did not correct the heights of the 
aggregates obtained in the presence of chaperones by 
the shrinking factor in this analysis, as this factor was 
determined for oligomers alone. Therefore, the aggre-
gate heights reported in Figure  3D should be compared 
with the uncorrected HypF-N oligomer height, which is 
1.66±0.09  nm (n = 101). As a control experiment, large 
aggregates were not observed in samples containing 
2.4 μm αBc alone, as reported previously (Mannini et al., 
2012).
In conclusion, since the concentration of HypF-N is 
4 μm in all cases, the measured increase in aggregate size 
following the addition of chaperones indicates that the 
HypF-N oligomers either assemble into larger aggregates 
in the presence of chaperones or recruit the chaperones 
themselves into the aggregates.
The large aggregates primarily contain 
HypF-N
To determine whether the large aggregates formed in the 
presence of 4 μm HypF-N and 16 μm αBc, Clu and M-TTR 
were constituted predominantly of HypF-N, or were com-
plexes of HypF-N and chaperone, we analyzed the samples 
using SDS-PAGE (Figure  4). In the samples containing 
HypF-N oligomers alone the HypF-N band (MW ~10.5 kDa) 
was present only in the P fraction (Figure 4). In the three 
samples containing only 16 μm αBc, Clu or M-TTR, the αBc 
band (MW ~20 kDa), the Clu band (MW ~36 kDa) and the 
M-TTR band (MW ~14 kDa) were found mainly in the SN 
fraction, although unexpectedly a weak band was also 
present in the P fraction, suggesting that a very small, yet 
significant, percentage of each of these proteins were in 
an aggregated state at these concentrations (Figure 4).
In the samples containing both HypF-N oligomers 
(4 μm monomer) and 16 μm chaperone the HypF-N band 
was visible only in the P fraction, whereas the bands 
representing αBc, Clu and M-TTR were visible in both 
the P and SN fractions, with the large majority of protein 
present in the SN fraction (Figure 4). For each of the three 
chaperones, the band intensity in the P sample containing 
oligomers and chaperone, determined using densitometry 
analysis, was weak and only slightly higher than that 
determined in the P sample containing chaperone alone. 
This result suggests that the large species observed when 
HypF-N oligomers were incubated at the highest chaper-
one concentration did not arise from the recruitment of all 
available chaperone to the HypF-N oligomers, but rather 
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Figure 3: AFM analysis of HypF-N oligomers.
(A–C) TM-AFM images (left, height data; right, amplitude data) of HypF-N oligomers (equivalent to 4 μm monomer concentration) pre-incubated 
with αBc (A), Clu (B), M-TTR (C) at the indicated chaperone concentrations. The scan size is 1.0 μm. The Z range is (with increasing chaperone 
concentration) 10 nm, 27 nm, 20 nm, 30 nm, 40 nm, 40 nm (A); 6 nm, 40 nm, 8 nm, 18 nm, 10 nm, 35 nm (B); 12 nm, 8 nm, 15 nm, 20 nm, 
120 nm, 12 nm (C). (D) The size of HypF-N aggregates in the presence of αBc (top), Clu (middle) or M-TTR (bottom) is measured from the topo-
graphic TM-AFM images as the maximum and minimum widths (right panels, red and black circles, respectively) and as the heights evaluated 
along the sections corresponding to the maximum and minimum widths (left panels, red and black circles, respectively).
from the further assembly of pre-existing HypF-N oligom-
ers induced by a small fraction of chaperone that remains 
associated with these assemblies.
Overall, the SDS-PAGE results show that (i) each 
chaperone is significantly insoluble at the concentration 
of 16  μm, (ii) each chaperone binds HypF-N oligomers 
only marginally, as the small fraction present in the pellet 
when both chaperone and oligomers are present results 
in part from the intrinsic insolubility of a small fraction of 
the chaperone at this concentration, (iii) the large aggre-
gates observed in the presence of both HypF-N oligomers 
and chaperone result from the chaperone-induced assem-
bly of HypF-N oligomers into larger species, which appear 
to consist predominantly of the HypF-N protein.
αBc, Clu and M-TTR partially aggregate at 
moderately high concentration
As further evidence that αBc, Clu and M-TTR aggregate 
at 16 μm concentration, we assessed the size distribu-
tions of αBc, Clu and M-TTR alone by light scattering 
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Figure 4: SDS-PAGE on samples containing HypF-N oligomers 
and αBc (A), Clu (B) and M-TTR (C). The samples were prepared by 
incubating HypF-N oligomers (4 μm monomer) and each chaper-
one (16 μm) separately or together. They were then centrifuged for 
10 min at 16 100 g and the P and SN fractions were collected and 
analyzed by reducing SDS-PAGE. The bands at ~10, ~20, ~36 and 
~14 kDa correspond to HypF-N (A–C), αBc (A), Clu (B) and M-TTR (C), 
respectively. In (B) a lower amount of unprocessed (single chain) 
and variably glycosylated Clu are also visible at higher molecular 
weights (black arrow).
(Figure 5). The peak at 18.8±0.4 nm observed in the pres-
ence of 16 μm αBc (Figure 5A) is consistent with the hydro-
dynamic diameter of native αBc (~13.5 nm), as reported 
previously (Haley et al., 1998; Burgio et al., 2001; Peschek 
et al., 2009). Indeed, αBc is an oligomer in its native state 
(Aquilina et al., 2003). In the sample containing Clu, the 
weak peak at 11.5±0.8 nm (Figure 5B) is consistent with the 
hydrodynamic diameter of native Clu, as reported previ-
ously (Wyatt et  al., 2009). This peak is partially masked 
by species of larger diameter, notably in the ranges of 
30–80 nm and 100–600 nm, indicating the presence of a 
variety of aggregates in solution. Since the intensity of 
light scattering scales with the square of the particle mass, 
the predominance of these peaks in the DLS intensity 
distribution does not indicate that most of Clu is aggre-
gated. Rather, the DLS intensity distribution indicates 
that most of the Clu adopts a native structure. However, it 
also provides evidence that aggregates are present. Aggre-
gates were also found in the samples containing M-TTR 
(Figure 5C), where they completely mask the peak related 
to the soluble form of M-TTR found at 4.5±0.6 nm (Jiang 
et al., 2001; Pires et al., 2012; Conti et al., 2014).
The presence of protein aggregates in samples con-
taining 16 μm chaperone was unexpected. We therefore 
repeated the experiments with Clu at this concentration, but 
in this case centrifuging and filtering (0.02 μm cutoff) the 
sample before measuring the DLS distributions at various 
time points. The aggregates appeared to be present from 
the start of the experiment, suggesting that they form and 
equilibrate very rapidly after centrifugation/filtration (data 
not shown). As all three chaperones were lyophilized after 
purification and resuspended immediately before the exper-
iments, these aggregates likely originate from the lyophili-
zation and resuspension procedure. We therefore analyzed 
by DLS a sample of Clu purified from human plasma that 
had not undergone lyophilization. The DLS distribution 
indicates that monomeric species are dominant, with only a 
very small number of aggregates of diameter 30–80 nm and 
no aggregates with a size larger than 100 nm (Figure 5D).
Overall, the DLS results confirm the data obtained 
by the SDS-PAGE analysis and suggest that lyophilized/
reconstituted αBc, Clu and M-TTR partially assemble into 
aggregates at the highest concentration studied here. 
Purified chaperones that have not been subjected to lyo-
philization and reconstitution do not, however, form sig-
nificant amounts of these aggregates. Similar behavior 
has been observed for α-synuclein (Chen et al., 2015).
Solvent-exposed hydrophobicity of HypF-N 
oligomers in presence of αBc, Clu and M-TTR
A number of studies indicate that an increase in the expo-
sure of hydrophobic groups on the surface of oligomers 
positively correlates with their ability to cause cellular dys-
function (Oma et al., 2005; Bolognesi et al., 2010; Olzscha 
et  al., 2011; Ladiwala et  al., 2012). This has also been 
observed for HypF-N oligomers (Campioni et al., 2010; Bem-
porad and Chiti, 2012). To investigate changes in the extent 
of exposed hydrophobicity on HypF-N oligomers following 
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the addition of chaperones, we measured the fluorescence 
of ANS in the presence of our samples. ANS is a fluorescent 
dye that binds to hydrophobic regions on the surface of 
proteins; this results in an enhanced quantum yield and in 
a blue shift of the wavelength of maximum emission (λmax) 
(Semisotnov et  al., 1991; Cardamone and Puri, 1992). The 
fluorescence spectra of ANS with HypF-N oligomers alone, 
αBc, Clu or M-TTR alone and HypF-N oligomers in the pres-
ence of αBc, Clu or M-TTR were acquired and compared 
to that of free ANS (Figure 6). The analysis was performed 
using HypF-N and chaperone concentrations of 48 μm and 
9.6 μm, respectively (Figure 6A–C) or 4 μm and 1 μm, respec-
tively (Figure 6D–F). This allowed to observe ANS binding 
under conditions in which chaperones do (Mannini et al., 
2012) or do not promote appreciable clustering of HypF-N 
oligomers in the first and second cases, respectively.
The binding of ANS to hydrophobic regions exposed 
on the HypF-N oligomers surface at high concentration 
(48 μm) results in enhanced quantum yield and in a blue 
shift of the wavelength of peak emission from 510–530 nm 
to 470–490 nm. Similar behavior was observed when 
9.6 μm αBc and Clu were analyzed separately indicating 
that these chaperones also have hydrophobic regions 
exposed on their surface. By contrast, such spectral 
changes were not observed in the samples containing 
M-TTR alone, suggesting that this protein, as expected for 
a fully folded protein, does not present clusters of exposed 
hydrophobic residues on its surface (Jiang et al., 2001).
For the sample containing both 48 μm oligomers and 
9.6 μm chaperone, under conditions in which the chaper-
one promotes clustering of HypF-N oligomers, the fluo-
rescence spectrum of ANS corresponds to that obtained 
from a linear combination (sum) of the ANS fluorescence 
spectra obtained with oligomers alone and chaperone 
alone (Figure 6A–C). This indicates that the oligomer 
surface hydrophobicity does not change after the binding 
of HypF-N oligomers to αBc, Clu or M-TTR under these 
conditions. By contrast, for the sample containing 4 μm 
oligomers and 1 μm chaperone, under conditions in which 
the chaperone does not promote a significant clustering 
of HypF-N oligomers, the fluorescence spectrum of ANS is 
lower in intensity than that obtained from a linear com-
bination (sum) of the ANS fluorescence spectra obtained 
with oligomers alone and chaperone alone at the same 
concentrations (Figure 6D–F). This indicates that the oli-
gomer surface hydrophobicity is weakly, yet significantly, 
Figure 5: DLS analysis of chaperones.
Size distributions by light scattering intensity of αBc (A), Clu (B), M-TTR (C) and Clu before lyophilization (D) at a concentration of 16 μm 
acquired after incubation of each chaperones for 1 h at 37°C with shaking in 20 mm potassium phosphate pH 7.0.
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Figure 6: ANS analysis of HypF-N oligomers. 
ANS fluorescence spectra in the absence of added proteins (purple), in the presence of HypF-N oligomers (blue), chaperone (red) and 
oligomers and chaperones incubated together (green). The reconstructed spectrum (black) is given by the sum of the spectra of HypF-N 
oligomers (blue) and chaperone incubated separately (red). The analysis refers to αBc (A,D), Clu (B,E) and M-TTR (C,F) with HypF-N and 
 chaperone concentrations of 48 μm and 9.6 μm (A–C) and 4 μm and 1 μm (D–F), respectively.
shielded after the binding to αBc, Clu or M-TTR under 
these conditions.
αBc, Clu and M-TTR inhibit HypF-N oligomer 
toxicity
The toxicity of HypF-N oligomers and αBc, Clu or M-TTR, 
preincubated together or separately, were tested using 
the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) assay on the murine neuroblastoma N2a 
cells. When the cells were treated with HypF-N oligomers 
at a concentration of 4 μm without chaperones, cell viabil-
ity was found to be 45.5±1.3% with respect to the untreated 
cells, taken as 100% (Figure  7A–C). In the presence of 
HypF-N oligomers preincubated with low concentrations 
of αBc, Clu or M-TTR, cell viability was greater, reaching 
about 80–85% of the untreated cells, at chaperone con-
centrations of 0.25 or 0.5 μm (Figure 7A–C). In similar 
experiments, cell viability decreased at higher chaperone 
concentrations, down to values of 50–58% at concentra-
tions of 16 μm chaperone. It is important to note, however, 
that for all chaperone concentrations tested, when HypF-N 
oligomers were preincubated with chaperone and then 
added to cells, the level of the toxicity measured was only 
slightly higher than that for the corresponding concentra-
tion of chaperone alone (Figure 7A–C). For example, the 
measured percent viable cells following incubation with 
4 μm HypF-N oligomers preincubated with 16 μm αBc, 
Clu and M-TTR were 50.7±3.2%, 52.6±2.3%, 57.7±4.0%, 
respectively, whereas the corresponding values for cells 
incubated with only 16 μm αBc, Clu and M-TTR were 
64.8±1.2%, 57.7±3.6%, 61.8±2.3%, respectively. These data 
indicate that the toxicity of the HypF-N oligomers is signif-
icantly inhibited by the chaperones and that the residual 
toxicity largely arises from the chaperone itself, probably 
from the fraction of chaperone in an aggregated form.
To test this possibility, we measured the toxicity of an 
identical sample of 16 μm Clu that had not undergone lyo-
philization and resuspension. No detectable toxicity was 
observed in this case, similarly to a protein sample con-
taining 16 μm BSA, used as a negative control, and unlike 
a sample containing toxic NaN3, used here as a positive 
control (Figure 7D). Overall, the results suggest that αBc, 
Clu and M-TTR inhibit HypF-N oligomer toxicity over the 
range of concentrations used here. The high levels of tox-
icity observed when the cells are coincidentally exposed 
to HypF-N oligomers and high concentrations of αBc, Clu 
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or M-TTR likely results from a small fraction of chaperone 
in an aggregated state, formed after the non-physiological 
procedure of lyophilization/reconstitution.
An early event arising from the cytotoxicity of protein 
oligomers is a rapid influx of Ca2+ ions from the cell culture 
medium into the cytosol, attributable to the interaction of 
the oligomers with the cell membrane (Bucciantini et al., 
2004; Demuro et  al., 2005, 2011; Zampagni et  al., 2011). 
We tested the effects on N2a cell Ca2+ dyshomeostasis of 
HypF-N oligomers alone, αBc, Clu or M-TTR alone, and 
HypF-N oligomers incubated with each of these three pro-
teins (Figure 8). The intracellular Ca2+-derived fluorescence 
of cells treated with HypF-N oligomers alone was remarka-
bly high, unlike untreated cells that presented a very weak 
intracellular fluorescence. The Ca2+-derived fluorescence 
of cells treated with HypF-N oligomers in the presence of 
αBc, Clu or M-TTR at 1 μm was significantly less evident 
than that derived from cells treated with HypF-N  oligomers 
alone and more similar to the fluorescence of untreated 
cells. A similar level of fluorescence was seen when cells 
were treated with 1 μm αBc, Clu or M-TTR alone. The fluo-
rescence of cells treated with HypF-N oligomers in the pres-
ence of 16 μm αBc, Clu or M-TTR was high, but similar to 
that of cells treated with either of the chaperones at the 
same concentration. These results confirm those obtained 
with the MTT assay and together indicate that the toxicity 
of HypF-N oligomers is inhibited at all concentrations of 
αBc, Clu or M-TTR investigated here.
Discussion
Effects of different concentrations 
of chaperones
Recently it has been demonstrated that, even when 
present at very low concentrations, molecular chaperones 
Figure 7: Cell viability assay following addition of HypF-N oligomers.
(A–C) MTT reduction assay on N2a cells after treatment with HypF-N oligomers and αBc (A), Clu (B) and M-TTR (C). The HypF-N oligomers (4 μm 
monomer) and each chaperone at the indicated concentration were incubated for 1 h at 37°C with shaking together or separately and then added 
to the cells. Each bar in the histogram represents the mean % of MTT reduction ± the standard error of the mean (SEM) of one experiment (n = 4). 
The single, double and triple asterisks indicate significant differences (p  ≤  0.05, p  ≤  0.01, p  ≤  0.001, respectively) between the indicated measure-
ments. (D) MTS assay on N2a cells after treatment with freshly purified Clu, BSA and NaN3 (AZ). Clu and BSA were incubated for 1 h at 37°C with 
shaking and then added to the cells. Each bar in the histogram represents the mean % of MTS reduction ± the standard error of the mean (SEM) 
of one experiment (n = 8). The triple asterisks indicate significant differences (p  ≤  0.001) between AZ and the other mesaurements.
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may inhibit the cytotoxicity of preformed misfolded oli-
gomers formed by Aβ, IAPP and HypF-N and fibrils formed 
by apolipoprotein C-II, by binding to them and convert-
ing them into larger aggregates (Ojha et al., 2011; Mannini 
et al., 2012, Binger et al., 2013). Interestingly, this chaper-
one-induced effect has been found to occur in the absence 
of any major structural reorganization within the indi-
vidual oligomers, which appear to maintain their overall 
structure and just assemble into larger species. This effect 
has also been observed in the presence of tetrameric TTR 
and, more so, with a variant engineered to be stable as a 
monomer, M-TTR (Cascella et al., 2013a). Here we found 
that the size of HypF-N aggregates increases with increas-
ing concentrations of αBc, Clu or M-TTR, as demonstrated 
by SLS and AFM. The analysis of the protein composition 
of the aggregates formed in the presence of a molar excess 
of αBc, Clu or M-TTR through SDS-PAGE revealed that the 
chaperones bind to the oligomers to only a limited extent. 
Indeed, most of the chaperone remains in the superna-
tant, suggesting that these large aggregates arise from the 
clustering of preexisting HypF-N oligomers, induced by 
a small fraction of chaperone molecules, rather than the 
recruitment of all available chaperone molecules to the 
HypF-N aggregates.
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Figure 8: Analysis of calcium influx following addition of HypF-N oligomers.
(A–C) Representative confocal scanning microscope images showing intracellular Ca2+ levels in N2a cells after treatment with HypF-N oligomers  
(4 μm monomer) incubated in the absence or in the presence of αBc (A), Clu (B) and M-TTR (C) at the concentration of 1 or 16 μm. Images of 
the cells treated with chaperones incubated separately at the concentration of 1 and 16 μm were also acquired. The green fluorescence arises 
from the intracellular Fluo3 probe bound to Ca2+. (D) Quantitation of intracellular Ca2+-derived fluorescence reported in panels (A)–(C). Each 
bar reports the mean and SEM (n = 4). The triple asterisks indicate significant differences (p  ≤  0.001) between the indicated measurements.
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allows apparent differences in the proposed mechanisms 
of action of chaperones to be reconciled. Indeed, the con-
comitant inhibition of oligomer toxicity and increased 
oligomer size induced by chaperones, via recruitment of 
more misfolded protein oligomers into the aggregates, has 
been interpreted to mean that chaperone-induced clus-
tering of oligomers is a strategy used by chaperones to 
inhibit oligomer toxicity (Ojha et al., 2011; Mannini et al., 
2012, Binger et  al., 2013; Cascella et  al., 2013a). By con-
trast, using single-molecule fluorescence techniques, it 
has been shown that clusterin and αBc are able to bind 
preformed oligomers of Aβ and sequester them from dis-
sociation or further growth into fibrils, revealing another 
possible mechanism of action of molecular chaperones 
which is binding in the absence of aggregate clustering 
(Narayan et al., 2011, 2012). In the case of Clu, the forma-
tion of complexes with misfolded proteins is thought to be 
relevant in the in vivo clearance of these aberrant species 
via membrane-associated receptors, such as the LRP-2 
receptor (Hammad et al., 1997; Cole and Ard, 2000; Bartl 
et al., 2001).
Comparison with previous studies
Previous reports have shown the effects of molecu-
lar chaperones at sub-stoichiometric concentrations 
(Mannini et al., 2012; Cascella et al., 2013a). Although in 
previous studies an increase in the size of HypF-N aggre-
gates was evident even at very low concentrations of 
chaperones (Mannini et al., 2012; Cascella et al., 2013a), 
the results presented here show that very large increases 
in aggregate size becomes significant only in the presence 
of higher chaperone:HypF-N molar ratios. This difference 
is probably due to the use of different protein concentra-
tions: in the previous studies HypF-N oligomers and chap-
erones were tested typically at concentrations of 12  μm 
(equivalent monomer concentration) and 1.2–4.8 μm, 
respectively, and we observed significant clustering of 
the HypF-N aggregates. By contrast, the HypF-N oligom-
ers were used here at concentrations of 4 μm (equivalent 
monomer concentration) and a significant increase of 
HypF-N oligomer size was observed at chaperone con-
centrations of 4.0 μm or higher. The lower concentration 
of HypF-N used here is theoretically expected to shift the 
equilibrium for the conversion of oligomers and chap-
erones to chaperone-oligomer complexes (and of the 
large assemblies of HypF-N) towards the ‘reagents’, i.e. 
increasing the population of the small oligomeric species 
of HypF-N and free chaperones, which is indeed experi-
mentally observed. Consequently, higher concentrations 
At 4 μm concentration (monomer equivalent) of 
HypF-N oligomers we have observed inhibition of toxic-
ity over the whole range of chaperone concentrations 
used in our experiments (0–16 μm), as demonstrated by 
the MTT reduction assay and Ca2+ influx measurements 
on N2a cells. The SLS and AFM analyses showed that in 
the presence of the lowest chaperone:HypF-N molar ratio 
tested here the oligomers maintain a size similar to that 
observed in their absence but have a significant shield-
ing of their hydrophobic surface, whereas in the presence 
of the highest molar ratio, the oligomers cluster together 
reaching a size much higher than that of free oligomers in 
the absence of a significant hydrophobic shielding. These 
results indicate that chaperones can inhibit the deleteri-
ous biological effects of HypF-N oligomers by binding to 
their surface without affecting their size, as well as by 
binding to them and inducing further growth of the aggre-
gated species (Figure 9). In the first case, the chaperones 
can bind to the hydrophobic groups exposed on the oli-
gomer surface, thus shielding them and preventing them 
from aberrant interactions with the cells. In the second 
case, the chaperones can cause a reduction of the surface-
volume ratio of the aggregates, decrease the effective 
concentrations of aggregated particles and decrease their 
diffusional mobility, as previously suggested (Mannini 
et al., 2012).
The protective effect mediated by chaperones against 
misfolded protein oligomers, and observed here in both 
the presence and absence of their further assembly, 
Low chaperone concentration
High chaperone concentration
HypF-N oligomers ChaperoneHydrophobic group
Figure 9: A cartoon representing the effect of molecular chaperones 
at low and high concentration, respectively.
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of chaperones were required in this work to determine a 
significant increase of HypF-N aggregate size.
Another significant difference between previous and 
present findings involves the extent of inhibition of HypF-N 
oligomer toxicity: previous reports showed a complete or 
nearly complete recovery of cell viability following the pre-
incubation of HypF-N oligomers with chaperones (Mannini 
et  al., 2012; Cascella et  al., 2013a), whereas the present 
experiments indicate levels of cell viability that were never 
higher than 85%, even at low concentrations of chaper-
one. This lower protective effect may be due to the higher 
sensitivity of N2a cells used here to measure oligomer tox-
icity compared to the SH-SY5Y cells used previously, but 
may also arise from the lower levels of chaperone-induced 
oligomer clustering reached under our conditions of sub-
stoichiometic concentrations of chaperones compared to 
previous studies (see above), which may render the chap-
erones less effective in their protective action.
Conclusions
The protective action of an intracellular chaperone, here 
αBc, an extracellular chaperone, here Clu, and the extracel-
lular protein with chaperone-like behavior M-TTR, has been 
evaluated against preformed HypF-N oligomers at different 
chaperone concentrations. The results show that the size of 
the HypF-N oligomers increases with chaperone concentra-
tion in all three cases and that the aggregates can reach a 
substantially greater size relative to free HypF-N oligomers 
with an associated reduction in aggregate toxicity. This pro-
tective effect has been observed at all chaperone concentra-
tions tested, emphasizing the efficiency and versatility of 
these protein molecules, which act to reduce toxicity both 
by binding to the oligomers without affecting their size and 
shield their hydrophobic surfaces and also by causing them 
to further assemble into larger species, with consequent 
reduction of their surface-volume ratio, effective concentra-
tions of aggregated particles and diffusional mobility.
Materials and methods
Formation of HypF-N toxic oligomers
HypF-N was expressed in E. coli cells and purified using an affinity 
chromatography column packed with the HIS-Select Nickel Affinity 
Gel (Sigma-Aldrich, St. Louis, MO, USA), as previously described 
(Campioni et  al., 2008). The purified native protein was stored at 
-80°C in 20 mm Tris, 2 mm DTT, pH 8.0 and used as a control (native 
HypF-N). Toxic oligomers of HypF-N were formed by incubating the 
native protein at a concentration of 48 μm for 4 h at 25°C in 50 mm 
acetate buffer, 12% (v/v) trifluoroethanol (TFE), 2 mm DTT, pH 5.5. 
The oligomers were collected by centrifugation at 16 100 g for 10 
min, dried under N2, and resuspended in either 20 mm potassium 
phosphate, pH 7.0 for biophysical/biochemical analysis, or in cell 
culture medium for cell biology tests. Unless stated otherwise, in 
all the experiments described below the oligomers were diluted into 
the same buffer or medium to a final protein concentration of 4 μm 
(corresponding monomer concentration), incubated for 1  h at 37°C 
with shaking in the presence of increasing concentrations of chap-
erones (ranging from 0 to 16 μm) and then subjected to biophysical/
biochemical analysis or cell biology assays.
Preparation of chaperones
Human αBc and M-TTR were purified from E. coli expression systems 
according to previously published protocols (Horwitz et  al., 1998; 
Jiang et al., 2001). Human Clu was purified from plasma as previously 
reported (Wilson and Easterbrook-Smith, 1992). Lyophilized chaper-
ones were dissolved in water and dialyzed against 20 mm potassium 
phosphate, pH 7.0, 4°C using a dialysis membrane with a molecular 
mass cut-off of 3500 Da (Spectrum Laboratories, Los Angeles, CA, 
USA). Most studies were conducted using liophilized and resus-
pended chaperones due to the necessity of shipping the samples 
between collaborating laboratories.
Light scattering measurements
HypF-N oligomers were first diluted in 20 mm potassium phosphate, 
pH 7.0, to final concentrations ranging from 0 to 14 μm (correspond-
ing monomer concentration) and then incubated without chaper-
ones for 1  h at 37°C while shaking. In another set of experiments, 
HypF-N oligomers at a corresponding monomer concentration of 
4 μm were incubated for 1 h at 37°C with shaking in 20 mm potassium 
phosphate, pH 7.0 in the presence of 0 to 16 μm αBc, Clu or M-TTR as 
described above. As a control, αBc, Clu and M-TTR alone at a con-
centration of 16 μm were also prepared under the same conditions. 
Before adding HypF-N oligomers and/or chaperones, all buffer solu-
tions were filtered using filters with a cut-off of 0.02 μm. Light scatter-
ing measurements were performed using a Zetasizer Nano S or APS 
(Malvern, Worcestershire, UK) thermostated with a Peltier tempera-
ture controller and using a low volume 3.0 × 3.0  mm cell or 96-well 
plate. All the measurements were acquired with fixed parameters 
(e.g. for the measurements performed on the Nano S the cell position 
4.20 mm, attenuator index 10) at 37°C.
Tapping mode atomic force microscopy (TM-AFM)
HypF-N oligomers were incubated in the presence of each chaperone 
as described above. Samples containing HypF-N oligomers incu-
bated in isolation and in combination of increasing concentrations 
of each chaperone were then diluted 100-fold; 10 μl aliquots of the 
diluted samples were deposited on freshly cleaved mica and dried 
under mild vacuum. Tapping mode AFM images were acquired in 
air using a Multimode SPM, equipped with ‘E’ scanning head (maxi-
mum scan size 10 μm) and driven by a Nanoscope V controller, and a 
Dimension 3100 SPM, equipped with a ‘G’ scanning head (maximum 
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scan size 100 μm) and driven by a Nanoscope IIIa controller (Digital 
Instruments, Bruker AXS GmbH, Karlsruhe, Germany). Single beam 
uncoated silicon cantilevers (type OMCL-AC160TS, Olympus, Tokyo, 
Japan) were used. The drive frequency was 290–340 kHz and the scan 
rate was 0.3–0.8 Hz. Aggregate sizes were estimated from heights and 
widths in cross section of the topographic AFM images. For aggre-
gates obtained in the presence of chaperones, to take into account 
possible asymmetries in the aggregate shape, we considered both 
the maximum and minimum widths and the corresponding heights 
evaluated along the same image sections.
SDS-PAGE
Oligomers of HypF-N (4 μm monomer equivalent concentration) were 
incubated with 16 μm αBc, Clu or M-TTR as described above. In con-
trol experiments oligomers alone and each chaperone alone were 
also incubated under the same conditions. Samples were then cen-
trifuged for 10 min at 16 100 g and the pellet (P) and supernatant (SN) 
fractions were subjected to sodium dodecylsulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis using 15% (w/v) polyacryl-
amide gels. Proteins were visualized by Coomassie Blue staining. In 
other experiments, samples containing native HypF-N and HypF-N 
oligomers were centrifuged for 10 min at 16 100 g and the P and SN 
fractions were analyzed by SDS-PAGE.
ANS fluorescence
HypF-N oligomers (48 μm or 4 μm monomer concentration) were 
incubated with 9.6 μm or 1 μm αBc, Clu or M-TTR, for 1  h at 37°C 
while shaking. Oligomers and each chaperone were also incubated 
separately under the same conditions. Aliquots of ANS dissolved in 
20 mm potassium phosphate, pH 7.0 were added to the oligomers in 
order to obtain a final 3:1 molar excess of dye. Samples with the same 
final ANS concentration and without HypF-N/chaperones were also 
prepared as controls. Fluorescence spectra were acquired using a LS 
55 spectrofluorometer (Perkin-Elmer, Waltham, MA, USA) equipped 
with a thermostated cell holder attached to a Thermo Haake C25P 
water bath (Karlsruhe, Germany) at 37°C and using a 10 × 2 mm quartz 
cell. The excitation wavelength was 380 nm.
Cell cultures
Murine Neuro2a (N2a) neuroblastoma cells (A.T.C.C., Manassas, VA, 
USA) were cultured in minimum essential medium eagle (MEM) sup-
plemented with 10% (v/v) fetal bovine serum (FBS), 1 mm glutamine 
and antibiotics (Sigma-Aldrich, St. Louis, MO, USA). Cell cultures 
were maintained in a 5% CO2 humidified atmosphere at 37°C and 
grown until 80% confluence for a maximum of 20 passages.
MTT and MTS assays
Cells were treated for 24 h with HypF-N oligomers (4 μm monomer) 
and chaperones (0–16 μm) pre-incubated in combination or in isola-
tion for 1  h at 37°C with shaking in cell culture medium. The MTT 
reduction assay was performed on N2A cell cultures as previously 
described (Campioni et al., 2010). In another experiment, N2a cells 
were seeded into the wells of a sterile 96-well plate to approximately 
30% confluence; the growth medium was 90 μl/well of 10% (v/v) FCS 
in DMEM:F12 (both from Trace Biosciences, Melbourne, Australia) 
containing penicillin/streptomycin. The following day, solutions of 
freshly purified Clu and BSA in PBS were gently incubated at 37°C 
for 1 h on an orbital shaker, and then added into quadruplicate wells 
to give a final concentration of ca. 1 mg/ml (i.e. 16 μm). The control 
wells received either no additions or 0.1% NaN3. The cultures were 
subsequently incubated overnight at 37°C and 5% (v/v) CO2, before 
performing a CellTiter 96 Aqueous One Solution Cell Proliferation 
(MTS) assay according to the manufacturer’s instructions (Promega, 
Fitchburg, WI, USA).
Measurement of intracellular Ca2+ levels
Oligomers of HypF-N (4 μm monomer) were incubated for 1 h at 37°C 
with shaking in cell culture medium with or without 1 μm or 16 μm 
of αBc, Clu, or M-TTR and then added to N2a cells seeded on glass 
coverslips for 60 min at 37°C. Cells were then loaded for 30 min with 
4.4 μm fluo3-AM (Life Technologies, Carlsbad, CA, USA) with 0.01% 
(w/v) pluronic acid F-127 (Sigma-Aldrich, St. Louis, MO, USA) in cul-
ture medium at 37°C. The cells were then washed with PBS and fixed 
for 10  min at room temperature with 2% (v/v) paraformaldehyde 
(Sigma-Aldrich, St. Louis, MO, USA) in PBS. Finally, the paraformal-
dehyde solution was removed and the coverslips were washed with 
PBS and water to be mounted on slides for the confocal microscopy 
analysis. Cell fluorescence was analyzed by a Leica TCS SP5 confocal 
scanning microscope (Leica Microsystems, Mannheim, Germany), as 
previously described (Campioni et al., 2010; Zampagni et al., 2011).
Statistical analysis
Data was expressed as mean±standard error of the mean (SEM). 
 Comparisons between group pairs were performed using the 
 Student’s t test. A p-value lower than 0.05 was considered statisti-
cally significant.
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